Affiliation:
1. Faculty of Pharmacy, Universitas Indonesia, Depok 16424, Indonesia
2. School of Pharmacy, Medical Biology Centre, Queen’s University Belfast, 97 Lisburn Road, Belfast BT9 7BL, UK
3. School of Life Sciences, Indonesia International Institute of Life Sciences, Jakarta 13210, Indonesia
Abstract
Medical practitioners commonly use oral and parenteral dosage forms to administer drugs to patients. However, these forms have certain drawbacks, particularly concerning patients’ comfort and compliance. Transdermal drug delivery presents a promising solution to address these issues. Nevertheless, the stratum corneum, as the outermost skin layer, can impede drug permeation, especially for macromolecules, genetic materials, stem cells, and secretome. Microneedles, a dosage form for transdermal delivery, offer an alternative approach, particularly for biopharmaceutical products. In this review, the authors will examine the latest research on microneedle formulations designed to deliver genetic materials, stem cells, and their derivatives. Numerous studies have explored different types of microneedles and evaluated their ability to deliver these products using preclinical models. Some of these investigations have compared microneedles with conventional dosage forms, demonstrating their significant potential for advancing the development of biotherapeutics in the future.
Reference97 articles.
1. U.S. Food and Drug Administration (FDA) (2023, October 23). Approved Cellular and Gene Therapy Products, Available online: https://www.fda.gov/vaccines-blood-biologics/cellular-gene-therapy-products/approved-cellular-and-gene-therapy-products.
2. Agyei, D., Tan, K.X., Pan, S., Udenigwe, C.C., and Danquah, M.K. (2017). Peptide Applications in Biomedicine, Biotechnology and Bioengineering, Elsevier.
3. Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability;Verma;Drug Dev. Res.,2021
4. Transferosomal in situ gel administered through umbilical skin tissues for improved systemic bioavailability of drugs: A novel strategy to replace conventional transdermal route;Gowda;Med. Hypotheses,2022
5. Shah, B., Surti, N., and Misra, A. (2011). Challenges in Delivery of Therapeutic Genomics and Proteomics, Elsevier.